Healthy Men: Study of Inno8 Dosing

We are researching how different doses of the medicine Inno8 work in the bodies of healthy men. This study may help us understand the best dosing for future treatments.

1-2 yearsSafety phase (I)AllergologyDermatologyDiabetologyEndocrinologyGynecology and ObstetricsHematologyInfectious DiseasesInternal MedicineNephrologyNeurologyOncologyOphthalmologyOrthopedics and TraumatologyOtolaryngologyPediatricsPsychiatryRheumatologyUrology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Charite Research Organisation GmbH
Berlin, Germany
Sponsor: Novo Nordisk A/S
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.